|1.||Veranič, Peter: 2 articles (01/2015 - 01/2012)|
|2.||Resnik, Nataša: 2 articles (01/2015 - 01/2012)|
|3.||Sepčić, Kristina: 2 articles (01/2015 - 01/2012)|
|4.||Macek, Peter: 2 articles (03/2007 - 08/2005)|
|5.||Diacci, Uroš: 1 article (04/2015)|
|6.||Vrecl, Milka: 1 article (04/2015)|
|7.||Frangež, Robert: 1 article (04/2015)|
|8.||Benoit, Evelyne: 1 article (04/2015)|
|9.||Babnik, Monika: 1 article (04/2015)|
|10.||Maček, Peter: 1 article (01/2015)|
01/01/2012 - "In the present study, a raft marker, ostreolysin, revealed the enrichment of cholesterol-sphingomyelin membrane nanodomains along ICNs in a T24 (malignant) urothelial cancer cell line. "
01/01/2015 - "Highly Selective Anti-Cancer Activity of Cholesterol-Interacting Agents Methyl-β-Cyclodextrin and Ostreolysin A/Pleurotolysin B Protein Complex on Urothelial Cancer Cells."
03/01/2007 - "Based on sequence similarities of ostreolysin and Asp-hemolysin, their comparable cytolytic effects towards different cells, and similar signs of intoxication in experimental animals, our results indicate that Asp-hemolysin might be considered as a possible virulence factor of Aspergillus fumigatus during the infection of bone and cartilage."
08/23/2005 - "pH-induced and thermally induced unfolding of ostreolysin was studied by means of CD, UV absorption, and intrinsic tryptophan fluorescence to characterize conformational transitions associated with its functional properties, i.e., binding to lipid membranes, pore forming activity on lipid vesicles, and hemolysis. "